Synapse - Works

Results (115370)

A randomized phase 2 trial of 28-day (Arm A) versus 14-day (Arm B) schedule of venetoclax + azacitidine in newly diagnosed acute myeloid leukemia patients ≥ 60 years

Meeting Abstract

Borate, U.; Huang, Y.; Zeidner, J. F.; Swords, R. T.; Koenig, K. L.; Stein, E. M.; Baer, M. R.; Stock, W.; Madanat, Y. F.; Olin, R.; more...
Blood (2024)

Fulltext@MSK | Save

Mosunetuzumab continues to demonstrate clinically meaningful outcomes in patients with relapsed and/or refractory follicular lymphoma after ≥ 2 prior therapies including those with a history of POD24: 4-year follow-up of a pivotal phase II study

Meeting Abstract

Shadman, M.; Bartlett, N. L.; Matasar, M.; Schuster, S. J.; Assouline, S. E.; Sehn, L. H.; Kuruvilla, J.; Giri, P.; Cheah, C. Y.; Dietrich, S.; more...
Blood (2024)

Fulltext@MSK | Save

Screening for AL amyloidosis in smoldering multiple myeloma

Meeting Abstract

Toskic, D.; Mansukhani, M.; Zhou, P.; Scalia, S.; Ma, X.; Fogaren, T.; Lee, L. X.; Chung, A.; Tuchman, S. A.; Bianchi, G.; more...
Blood (2024)

Fulltext@MSK | Save

Tumor determinants of response to CAR-T therapy in relapsed or refractory mantle cell lymphoma

Meeting Abstract

Epstein-Peterson, Z. D.; Ryan, C. E.; Devlin, S. M.; Accav, N. G.; Avigdor, A.; Corona, M.; Danylesko, I.; Dela Cruz, J.; Goy, A.; Jacobson, C. A.; more...
Blood (2024)

Fulltext@MSK | Save

The prognostic and predictive value of RUNX1 mutations in newly diagnosed acute myeloid leukemia - An international multicenter cohort study

Meeting Abstract

Bystrom, R. P.; Bewersdorf, J. P.; Liu, Y.; Schaefer, E. J.; Shallis, R. M.; Boussi, L.; Zucenka, A.; Garciaz, S.; Aguirre, L. E.; DeAngelo, D. J.; more...
Blood (2024)

Fulltext@MSK | Save

Lisocabtagene maraleucel (liso-cel) in patients (pts) with relapsed or refractory (R/R) follicular lymphoma (FL): TRANSCEND FL 2-year follow-up

Meeting Abstract

Nastoupil, L.; Dahiya, S.; Palomba, M. L.; García-Sancho, A. M.; Reguera, J. L.; Kuruvilla, J.; Jaeger, U.; Cartron, G.; Izutsu, K.; Dreyling, M.; more...
Blood (2024)

Fulltext@MSK | Save

Combined human and in vivo analyses implicate the critical importance of acute myeloid leukemia associated CD8 T cells and identifies their molecular dysfunction

Meeting Abstract

Chu, Y. E.; Cottam, M. A.; Potts, C. R.; Dickerson, K. M.; Jenkins, M. T.; Cartailler, J. A.; Lu, R.; Lee, S. C.; Levine, R. L.; Bowman, R. L.; more...
Blood (2024)

Fulltext@MSK | Save

Genomic determinants of resistance to anti-BCMA chimeric antigen receptor T-cell (CART) therapies in patients with relapsed/refractory multiple myeloma

Meeting Abstract

Maura, F.; Freeman, C. L.; Lee, H.; Maclachlan, K. H.; Durante, M.; Ziccheddu, B.; Menges, M.; Diamond, B.; Papadimitriou, M.; Silva, A. S.; more...
Blood (2024)

Fulltext@MSK | Save

Genomic complexity correlates with the degree of marrow independence of malignant plasma cells in the context of extramedullary disease

Meeting Abstract

Maclachlan, K. H.; Garces, J. J.; Shekarkhand, T.; Rajeeve, S.; Hashmi, H.; Hassoun, H.; Hultcrantz, M.; Korde, N.; Tan, C. R.; Mailankody, S.; more...
Blood (2024)

Fulltext@MSK | Save

Mutant RUNX1, SETBP1 and IDH mutant allele dynamics as biomarkers of hematologic response to IDH inhibitors in myeloid malignancies

Meeting Abstract

Chernak, B.; Song, A.; May, B.; Viny, A. D.
Blood (2024)

Fulltext@MSK | Save